Search:

< Go Back

U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis
Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer
Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings
Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China
Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies
Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients
Actavis And Kissei File Lawsuits Against Sandoz And Hetero For Infringement Of Rapaflo® Patent
Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall
Pharma IQ Presents the Latest Trends in Clinical Trial Supply
RXi Pharmaceuticals Corporation Begins Trading on OTCQX®
Aurigene and Debiopharm Group™ Report Nomination of Development Candidate Debio 0617B in Oncology
"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference
Safinamide Phase III Study Results Presented at 2013 MDS Meeting
Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes
Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Valeant Pharmaceuticals Prices Public Offering Of Common Shares
Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition
Feosol® Iron Supplements Named #1 Pharmacist Recommended Brand for 2013-2014 by U.S. News & World Report and Pharmacy Times
Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints
Lilly Declares Third-Quarter 2013 Dividend
One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs
Decision Resources' Market Access Tracker Now Covers the Middle East and Africa
MPR Sports a Bold New Look
Mandated Flu Vaccine for Hospital Workers Ethically Questionable, Surgeon Writes
New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors
Mei Pharma Initiates Phase II Clinical Trial Of Pracinostat And Vidaza® In Frontline Myelodysplastic Syndrome
Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease
AMRI Burlington Receives DEA Approval to Handle Controlled Substances
Latest Data for Type 2 Diabetes Treatment INVOKANA™ (canagliflozin) to be Presented at American Diabetes Association Annual Meeting
Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House
Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign
Moffitt Cancer Center Announces Strategic Partnership with Advinus Therapeutics
Purdue Pharma L.P. To Present Data Describing Changes in Oxycodone Abuse in Rural Kentucky Following the Introduction of Reformulated OxyContin® (Oxycodone HCl Controlled-Release) at the College on Problems of Drug Dependence 2013 Annual Meeting
Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
Boston Scientific Begins Patient Enrollment In U.S. Clinical Trial For Use Of Vercise™ DBS System In Treatment Of Parkinson's Disease
BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend
Valeant Pharmaceuticals Announces Public Offering Of Common Shares
DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus
Specialty Pharmacy Certification Board™ (SPCB™) Partners with Heuristic to Launch CSP™ Credentialing Management System
Weiler Labeling Introduces Serialization-Capable X-4S Labeling Head
A Win for Families: Urban Outfitters Halts Prescription Drug Paraphernalia Product Sales
Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America
Generex Announces $1,225,000 Capital Investment
Supreme Court Ruling on Rx Industry's Pay-to-Delay-Generics Good News for NY Consumers
New drug proving effective in attacking advanced prostate cancer
Suit filed for Pancreatic Cancer By Use of Byetta, Januvia and Janumet
Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO
U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis
New Data Showed LIVALO® (pitavastatin) 4 mg had Neutral Effects on Fasting Serum Glucose and HbA1c Levels in HIV-infected Adults with Dyslipidemia

< Prev Next >
PR Newswire - United Business Media